WebBusiness entity registration information for Curatis Pharma GmbH. Legal address, headquarters, subsidaries and parent company records. WebPipeline. Curatis identifies potential drug candidates in indications with high unmet medical need via its extensive network within the scientific and medical community, as well as within the biotech/pharmaceutical industry. Curatis invests a significant portion of its revenues and resources in its development activities. The current pipeline ...
Curatis Pharma GmbH, Hannover - Credit Report
WebFounded in 2002 by experienced industry executives, Curatis AG is a privately owned specialty pharmaceutical company based in Switzerland. "We focus on the acquisition, development and commercialisation of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases." About Curatis AG. Founded in 2002 by experienced industry executives, Curatis … Team Günter Graubach - Founder & Chairman of the Board of Directors. … Products. Curatis is passionate about specialist health care professionals … Curatis identifies potential drug candidates in indications with high unmet medical … Curatis Core competencies: speciality care drugs, orphan drugs as well as … Innovative Specialist Medicines. Programm & Anmeldung www.morbus … Curatis AG Weierweg 7 CH-4410 Liestal, Switzerland. P: +41 61 927 8777 F: +41 … The material provided in this site is presented solely to improve public … Curatis AG Dr. Roland Rutschmann Weierweg 7 CH-4410 Liestal, … WebCuratis Pharma GmbH, Pharmaceutical company profile, Lower Saxony, Germany ..., see full contact details theoretical model of health
CURATIS GmbH LinkedIn
WebActavis Switzerland AG, Apotex, Arrow Génériques, Biomed 2002 Inc., Curatis AG, Desitin Pharma GmbH, European Generics (EG), Impexeco, Pharmascience, Pro Doc Limitée, Roche, Teva, Valeant Pharmaceuticals Statut légal; Statut légal: Durée de prescription limitée à douze semaines [15] Remboursement: Taux de remboursement à 65% (France ... Web2002: PROREO PHARMA founded by Günter Graubach and Rudolf Syz. Since then the company has quickly built-up a sizeable portfolio of interesting specialist products and has grown rapidly. 2003: Acquired the rights to Terlipressin (trademark: Haemopressin®) for the treatment of esophageal varices bleeding and hepatorenal syndrome from Curatis … WebThis site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group. theoretical model of health education